Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease. A Single Technology Appraisal

Cooper, Keith, Picot, Joanna, Onyimadu, Oluchukwu, Shepherd, Jonathan, Lord, Joanne and Scott, David A. (2018) Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease. A Single Technology Appraisal (Health Technology Assessment, HTA - NIHR127473) Southampton. National Institute for Health and Care Research 128pp.

Record type: Monograph (Project Report)

Abstract

This report is a critique of the company’s submission (CS) to NICE from Bayer on the clinical effectiveness and cost effectiveness of rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease. It identifies the strengths and weakness of the CS. Clinical experts were consulted to advise the ERG and to help inform this review.

Text

rivaroxaban - Version of Record

Download (1MB)

More information

Published date: 2018

Related URLs:

Identifiers

Local EPrints ID: 437769

URI: http://eprints.soton.ac.uk/id/eprint/437769

PURE UUID: e309a4a6-a6f6-4b9a-9003-991764a058d5

ORCID for Keith Cooper:

orcid.org/0000-0002-0318-7670

ORCID for Joanna Picot:

orcid.org/0000-0001-5987-996X

ORCID for Oluchukwu Onyimadu:

orcid.org/0000-0002-1724-3485

ORCID for Jonathan Shepherd:

orcid.org/0000-0003-1682-4330

ORCID for Joanne Lord:

orcid.org/0000-0003-1086-1624

Catalogue record

Date deposited: 14 Feb 2020 17:33

Last modified: 10 Apr 2024 01:50

Export record

Share this record

Share this on Facebook Share this on Twitter Share this on Weibo

Contributors

Author: Keith Cooper

Author: Joanna Picot

Author: Oluchukwu Onyimadu

Author: Jonathan Shepherd

Author: Joanne Lord

Author: David A. Scott

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information